Ayala Pharmaceuticals Inc (ADXS)
0.57
-0.08
(-11.70%)
USD |
OTCM |
Apr 18, 16:00
Ayala Pharmaceuticals EPS Diluted (TTM): -8.751 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.751 |
September 30, 2023 | -10.18 |
June 30, 2023 | -11.48 |
December 31, 2022 | -10.32 |
September 30, 2022 | -7.66 |
June 30, 2022 | -4.83 |
March 31, 2022 | -2.75 |
December 31, 2021 | -2.83 |
Date | Value |
---|---|
September 30, 2021 | -2.90 |
June 30, 2021 | -2.81 |
March 31, 2021 | -2.80 |
December 31, 2020 | -2.605 |
September 30, 2020 | -2.507 |
June 30, 2020 | -2.505 |
March 31, 2020 | -2.206 |
December 31, 2019 | -2.074 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-11.48
Minimum
Jun 2023
-2.074
Maximum
Dec 2019
-4.950
Average
-2.82
Median
EPS Diluted (TTM) Benchmarks
Taro Pharmaceutical Industries Ltd | 1.22 |
InspireMD Inc | -1.05 |
BiomX Inc | -0.53 |
Alpha Tau Medical Ltd | -0.42 |
Pluri Inc | -4.64 |